Quince Therapeutics's current assets is $120M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Quince Therapeutics (QNCX) currently reports a current assets of $120M as of June 2026. That compares with $37M in the prior-year period — up 230.5% year over year. Use the charts on this page to explore Quince Therapeutics's current assets history and peer comparisons.
Quince Therapeutics's current assets increased from $37M to $120M — a 230.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Quince Therapeutics reported $120M in current assets as of June 2026. That compares with $37M in the prior-year period — up 230.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current assets of $120M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Quince Therapeutics, and consider following QNCX for alerts when major investors trade the stock.
Quince Therapeutics is classified in the Healthcare sector. On current assets, it currently shows $120M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing QNCX with unrelated industries.